Exhibitor Showcase Schedule

Schedule At A Glance

 

 Tuesday, May 16Wednesday, May 17Thursday, May 18
Time   
10:30 AMSilicycleFresenius Kabi 
11:00 AMThermo Fisher ScientificLGM 
11:30 AMGrifolsSharp Packaging 
12:00 PMEsteve QuimicaCatalent 
12:30 PMJ-Star ResearchFuture Fuel Chemical Company 
1:00 PMB+W TekOptima Chemical  
1:30 PMPiramalUNIPHARMA LLC  
2:00 PMKodakMitsubishi Gas Chemical Company, Inc. 
2:30 PMBachem Americas IncAustin Chemical   
3:00 PMCorning SASsfm Medical Devices, USA, Inc.  
3:30 PMAptar PharmaEscientia 
4:00 PMSolid Form SolutionsGesellschaft fur Micronisierung 
4:30 PM   

Session Information

Tuesday 10:30 - 10:55 AM

Silicycle

Mark Cabell
Tuesday 11:00 - 11:25 AM

Thermo Fisher Scientific

Oriol Prat - Director Contract Manufacturing Grifols Partnership

Reducing Risk During Preparation Admixtures

Tuesday 11:30 - 11:55 AM

Grifols

There is a need for needle free valve bags to provide safe handling during preparation of admixtures in pharmacies. Pharmacists, nurses and physicians are particularly vulnerable to puncture and contamination during the process assuming health risk.

Manuel Lourenco, Business Development Director

Manufacturing solutions for the health care industry

Tuesday 12:00 - 12:25 PM

Esteve Quimica

Esteve Química has more than 50 years’ experience developing, manufacturing and marketing oral and injectable-non-sterile APIs (NCEs and generics) for regulated markets. Our cGMP’s multipurpose plants (two in Spain (EQ Esteve), one in Mexico (Sintenovo) and one in China (EHP)) have a total capacity of more than 800m3. Our services include process and analytical development, scale-up, analytical transfer, validation, process optimization and commercial manufacturing, along with any required technical services. In 2016, we have added Spray Drying and HAPI manufacturing capabilities. Please find out more about Esteve Química at www.estevequimica.com

Andrew Thompson
Tuesday 12:30 - 12:55 PM

J-Star Research

Dr. Katherine Bakeev, Director of Market and Customer Development

Raman to See Through Containers and Coatings

Tuesday 1:00 - 1:25 PM

B+W Tek

Portable and handheld Raman systems with easy, intuitive operation are the tools of choice for raw material identification and research. The applicability of Raman is expanded with a new portable system featuring See_Through™ technology, which enables material identification inside visually opaque barriers such as white plastic bottles, paper envelopes, and coatings. The ST technology features a large sampling area and minimized power density, facilitating the measurement of heterogeneous materials and darker materials that would be susceptible to photo damage under conventional Raman spectroscopy.

Ramesh Subramanian, General Partner

What you always wanted to know about integrated programs, but were afraid to ask.

Tuesday 1:30 - 1:55 PM

Piramal

The growing number of clinical development projects coupled with cost rationalization initiatives, have led to a mismatch on internal resources that are required to manage drug substance and drug product sourcing needs at pharmaceutical firms. Increasingly, biotech and large pharmaceutical firms rely on global service providers that they can partner with for both their API and drug product needs. In this presentation, we describe Piramal’s approach towards integrated collaborations, our learnings, and our track record on executing integrated programs that include both drug substance/product and sites located in various geographies. 

Rajiv (Bala) Balasubramaniam, Ph.D., Technical Director, Kodak Specialty Chemicals
Tuesday 2:00 - 2:25 PM

Kodak

Tuesday 2:20 - 2:55 PM

Bachem Americas Inc

Dr Yi Jiang, Business Director, Asia Emerging Business Development & Global Reactor Technologies
Tuesday 3:00 - 3:25 PM

Corning SAS

Stefan Hellbardt

Growing Confidence in Airless Dispensing

Tuesday 3:30 - 3:55 PM

Aptar Pharma

Airless Dispensing Solutions from Aptar Pharma perfectly meet the requirements for the growing market for pharmaceutical semi-solid formulations for topical application.

Stephen Watt, CEO
Tuesday 4:00 - 4:25 PM

Solid Form Solutions

Stefan Czvitkovich, PhD, Director PP Sterile Pharmaceuticals

Contract Manufacturing Services for Pre-filled Syringes – From Standard Solutions to Complex Products

Wednesday, 10:30 - 10:55 AM

Fresenius Kabi

Fresenius Kabi Product Partnering offers contract manufacturing services for sterile liquid injectable drugs from more than 20 manufacturing sites worldwide. Here, we introduce two of our FDA approved sites and their fill/finish capabilities for pre-filled syringes for third party manufacturing. The Fresenius Kabi sites in Wilson, NC and Graz, Austria can accompany our partners during process development and upscaling through to clinical and commercial batch manufacture. Our experience with different pre-filled syringe suppliers and scales enables us to offer drug product manufacture from standard solutions to complex formulations.

Gideon Schurder, Commercial Director, LGM

The Unfortunate Aftermath of the US-FDA Slamming API Factories

Wednesday, 11:00 - 11:25 AM

LGM

An in-depth look at the calamitous effects of recent FDA warning letters and import bans and how this affects the pharmaceutical industry; API manufacturers and formulation companies. Prime examples of how API factories should have acted to avoid getting themselves into hot water. How does all of this affect end patients and what the Trump administration can do in order to mitigate the outcome.

Gaurav Banerjee - Director of Technical Services and Enterprise Applications

Unrealized Effects of Implementing Serialization

Wednesday 11:30 - 11:55 AM

Sharp Packaging Solutions

Wednesday, 12:00 - 12:25 PM

Catalent

Andrew Skinner, Director of Business Development

Overview of the Capabilities of FutureFuel Manufacturing Facility

Wednesday, 12:30 - 12:55 AM

Future Fuel Chemical Company

FutureFuel Chemical Company (FFCC) is a public company (NYSE:FF) which is 10 year young, but our plant has been in operation for 40 years.  Starting in 1976 with chemicals for Kodak film, FFCC has history rich in complex organic synthesis.  Our plant site is located on 2200 acres located near Batesville, AR.  We have approximately 500 employees and we are non-union.  We generate approximately $300M in revenue and manufacture products for agriculture, oilfield and automotive applications.  Process hazard evaluation, scale-up, and analytical chemical are some of our many strengths.  FFCC is a member of the American Chemistry Council and a Responsible Care site.  Forbes magazine recently named FFCC one of the top 100 most trustworthy companies in America.

Doug Cochran, General Manager
Wednesday, 1:00 - 1:25 PM

Optima Chemical

Wednesday, 1:30 - 1:55 PM

UNIPHARMA LLC

Mr. Takumi Toida, Researcher, Mitsubishi Gas Chemical Company, Inc.

Multilayer Plastic Vial & Syringe with Glass-like Oxygen Barrier for Biologics

Wednesday, 2:00 - 2:25 PM

Mitsubishi Gas Chemical Company, Inc.

We are pleased to introduce multilayer plastic vial & syringe with glass-like oxygen barrier. Although glass is commonly used for parenteral packaging for many years, some disadvantages such as breakage, metal extractables, delamination, protein adsorption, etc. have been pointed out recently. As one of alternative materials, COP or COC is often applied to plastic vials and syringes but the oxygen barrier is much inferior to glass. To overcome every defect of current containers, we have developed OXYCAPT plastic vial and syringe consisting of 3 layers.

Wednesday, 2:30 - 2:55 PM

Austin Chemical

John Mullin, Director of Sales, sfm Medical Devices, USA, Inc.

Nextaro - The Quality Benchmark for the Reconstitution of Lyophilized Pharmaceuticals

Wednesday, 3:00 - 3:25 PM

sfm Medical Devices, USA, Inc.

With its key advantages being the patented screw system, providing the best stability available in the reconstitution market, combined with optimized handling through the use of two component plastic, Nextaro is the premier solution for those in a hurry or those with ailments making reconstitution difficult.  The modular design makes Nextaro customizable to meet the individual requirements of each pharmaceutical compound. Join us to learn more about how to include Nextaro in your high quality application set, giving it the device it deserves.

Yadagiri Pendri Ph.D., CEO

Escientia Life Sciences – Discover, Develop, Deliver

Wednesday, 3:30 - 3:55 PM

Escientia

Hebrert Hansen, Advisory Board

Micronistation Under GMP Conditions

Wednesday, 4:00 - 4:25 PM

Gesellschaft fur Micronisierung